Core Insights - Prenetics Global Limited reported a significant revenue growth of 93.5% to $10.5 million in Q4 2024 and a year-over-year increase of 40.9% to $30.6 million for the full year 2024 [1][9][13] - The company has cash and short-term assets totaling $84.8 million as of December 31, 2024, positioning it well for future growth opportunities [1][6] - For 2025, Prenetics projects full-year revenue between $73 million and $85 million, driven by the successful launch of its IM8 Health brand [2][12] Financial Performance - In Q4 2024, Prenetics achieved a gross profit of $4.6 million, up 73.1% from $2.7 million in Q4 2023, with a gross margin of 44.0% [9][13] - The full-year gross profit for 2024 was $16.1 million, an increase of 82.6% from $8.8 million in 2023, with a gross margin improvement to 52.6% from 40.6% [9][13] - Adjusted EBITDA loss for Q4 2024 was $(6.8) million, slightly worse than $(6.1) million in Q4 2023, while the full-year adjusted EBITDA loss improved to $(22.2) million from $(24.8) million in 2023 [9][13] Business Strategy and Growth - The company is focusing on its consumer health brands, including IM8, Europa, and CircleDNA, which are expected to drive significant growth [6][11] - IM8 Health has quickly gained traction in the market, establishing a strong community and positioning itself in the holistic health sector [4][6] - Strategic acquisitions, such as Europa, are expected to contribute to revenue growth, with Europa projected to break even by the second half of 2025 [5][6] Future Outlook - Prenetics anticipates a robust revenue increase of 350-450% year-over-year for 2025, aiming for profitability by the end of Q4 2025 [6][12] - The company expects Q1 2025 revenue to be between $11.5 million and $13 million, with specific contributions from IM8, Europa, and CircleDNA [8][12]

Group 1 - The New York Stock Exchange (NYSE) provides a daily pre-market update to offer market insights before trading begins [1][3] - Target (NYSE: TGT) reported Q4 earnings that exceeded expectations, driven by an increase in comparable sales [3] - Best Buy (NYSE: BBY) also surpassed Q4 estimates, experiencing a sales uptick and announcing a dividend boost [3] - Stock futures are showing a slight increase, recovering from previous declines [3]

Group 1 - The New York Stock Exchange (NYSE) provides a daily pre-market update to offer market insights before trading begins [1] - The Dow Jones Industrial Average continued to gain, supported by earnings from Home Depot (NYSE: HD) [1] - Nvidia is scheduled to report its earnings after the market closes on the same day [1] Group 2 - Markets closed mixed on the previous day as investors are weighing economic concerns and upcoming data [1]

Group 1 - Home Depot (NYSE: HD) and Lowe's (NYSE: LOW) are scheduled to report earnings this week [1] - Nvidia is set to report earnings on Wednesday [1] - Investors are anticipating a new week of key economic and inflation data [1]

Group 1 - The New York Stock Exchange (NYSE) provides a daily pre-market update to offer market insights before trading begins [1][3] - Walmart shares are nearing all-time highs following the release of its earnings report [3] - The S&P 500 index has risen to a record level, despite the Federal Reserve's cautious stance on interest rates [3] Group 2 - President Trump has proposed the idea of implementing tariffs on automobiles, chips, and pharmaceuticals [3]

Group 1 - Nike and Skims have launched a new brand for women called NikeSKIMS [2] - Investors are anticipating a speech from Federal Reserve Vice Chair Philip Jefferson [2] - Key housing data, including housing starts and building permits, is set to be published [2] Group 2 - The New York Stock Exchange (NYSE) provides a daily pre-market update for market insights [1] - Trinity Chavez delivered the pre-market update on February 19th [1] - NYSE TV Live is available every weekday from 9:00-10:00am ET [1]

NEW YORK, Feb. 14, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on February 14th NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 14th + KARMAN POPS DOUBLE DIGIT IPO Karman Holdings (NYSE: KRMN) sees stock jump in NYSE debut Stocks gain as President Trump holds off on new ...

Core Insights - Prenetics Global Limited has announced a partnership with Humanity Protocol to integrate its CircleDNA service for decentralized identity verification, utilizing advanced genetic testing capabilities [1][2] - The collaboration aims to issue blockchain-based Proof of Personhood credentials, enhancing security and privacy in identity verification across various sectors [2][4] - Prenetics has established a Crypto Strategic Reserve with initial investments of $1 million in $H tokens, $250,000 in Bitcoin, and $250,000 in Solana, reflecting its commitment to blockchain innovation [3][4] Company Developments - Prenetics is advancing its initiatives in decentralized science (DeSci) through its joint venture, Insighta, which focuses on AI-driven early cancer detection and has received a $30 million investment from Tencent [5][6] - The company’s consumer health brand, IM8, is also contributing to the DeSci space by promoting health and longevity through scientific advancements [5][7] - Prenetics' financial position is strong, with cash and short-term assets totaling $84.87 million as of December 31, 2024, supporting its investment strategies [3][6] Industry Context - The partnership with Humanity Protocol represents a significant step in merging genomics with blockchain technology, aiming to enhance secure identity verification and healthcare solutions [4][6] - The growing focus on decentralized identity solutions is indicative of broader trends in the Web3 ecosystem, where privacy and security are paramount [8][9] - Prenetics' initiatives in DeSci and AI-driven healthcare solutions highlight the increasing intersection of technology and health sciences, aiming to redefine innovation in global healthcare [5][6]

The Next Big Thing in Wellness? IM8 Lands in the U.S. with a Star-Studded Launch. David Beckham and a world-class scientific team are putting the focus back on foundational health CHARLOTTE, N.C., Jan. 21, 2025 (GLOBE NEWSWIRE) -- IM8, a premium supplements brand co-founded by David Beckham, hosted its U.S. unveiling event in New York City on January 14. The two-part event featured an Inside Out Wellness session with holistic health advocate Deepak Chopra, M.D., and David Beckham, followed by An Evening wit ...

– David Beckham Co-Founded Premium Supplements Brand Sets the Standard for Science-Backed Excellence – Tested for 280+ banned substances, trusted by global athletes in WADA, NFL, NBA, MLB, PGA and more – IM8 is available at IM8health.com, shipping to 31 countries and regions CHARLOTTE, N.C., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Prenetics’ IM8, a premium supplements brand co-founded by David Beckham, announces its flagship product, Daily Ultimate Essentials, has been certified to NSF Certified for Sport®, a glo ...